SCHEMBL7445829

SCHEMBL7445829

CCN(Cc1ccccc1)C(=O)[C@H](Cc1ccccc1)Nc1nc2c(Br)cc(NC(=O)OC(C)(C)C)c(C)c2c(=O)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.46
CTRB1 P17538 2/20 0.46
ACE P12821 1/20 0.33
CTSL P07711 2/20 0.33
P2RX7 Q99572 1/20 0.33
ALDH1A1 P00352 2/20 0.33
PSEN1 P49768 2/20 0.33
PSEN2 P49810 2/20 0.33
APH1B Q8WW43 2/20 0.33
NCSTN Q92542 2/20 0.33
APH1A Q96BI3 2/20 0.33
PSENEN Q9NZ42 2/20 0.33
JAK2 O60674 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7438567 0.87 ELANE (0.63) ELANECTRB1CTSLP2RX7ALDH1A1
SCHEMBL6506922 0.84 ELANE (0.41) ELANECTRB1ALDH1A1LMNAHPGD
SCHEMBL7851384 0.84 ELANE (0.49) ELANECTRB1ACECTSLALDH1A1
SCHEMBL6801336 0.81 ELANE (0.38) ELANELMNANPC1
SCHEMBL7444707 0.81 ELANE (0.39) ELANECTRB1ACECTSLKMT2A
SCHEMBL6801293 0.81 ELANE (0.41) ELANEALDH1A1LMNAHPGDHTT
SCHEMBL6497577 0.79 ELANE (0.40) ELANELMNAKMT2A
SCHEMBL6805137 0.78 ELANE (0.39) ELANELMNAKMT2ANPC1
SCHEMBL6801500 0.78 ELANE (0.42) ELANECTRB1HPGDKMT2ANPC1
SCHEMBL7445664 0.78 ELANE (0.40) ELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996037485-A1 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS G.D. SEARLE & CO. (US) 1996-11-28 WO disclosed